Find More Contacts for Ceregene
Protected Content
Engineer
Non-Management Engineering
1 email found
View contacts for Ceregene to access new leads and connect with decision-makers.
View All Contacts
  • Company Type For Profit
  • Contact Email info@ceregene.com
  • Phone Number (858)458-8800

Ceregene is a private, San Diego-based biotechnology company focused on the treatment of major neurodegenerative disorders using the delivery of nervous system growth factors. Their clinical programs include CERE-110, an AAV2 based vector expressing nerve growth factor, which is about to enter Phase 2 studies for the treatment of Alzheimer's

disease, and CERE-120, which recently completed a Phase 2 trial in Parkinson's disease and is currently being evaluated for future development. CERE-135 and CERE-140 are in preclinical development for amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) and ocular diseases, respectively.

Lists Featuring This Company

Genentech Alumni Founded Companies
100 Number of Organizations • $15.6B Total Funding Amount • 504 Number of Investors
Private Greater San Diego Area Companies (Top 10K)
9,793 Number of Organizations • $49.8B Total Funding Amount • 5,308 Number of Investors
Greater San Diego Area Companies With Fewer Than 100 Employees (Top 10K)
9,484 Number of Organizations • $36.8B Total Funding Amount • 4,629 Number of Investors
United States Pharmaceutical Companies
9,939 Number of Organizations • $340.2B Total Funding Amount • 8,747 Number of Investors
on Aug 26, 2013. This deal was done in Stock.

Frequently Asked Questions

Where is Ceregene's headquarters? Ceregene is located in San Diego, California, United States.Who invested in Ceregene? Ceregene has 8 investors including Michael J. Fox Foundation and Alta Partners.How much funding has Ceregene raised to date? Ceregene has raised .When was the last funding round for Ceregene? Ceregene closed its last funding round on Nov 11, 2010 from a Series D round.Who are Ceregene's competitors? Alternatives and possible competitors to Ceregene may include Celator PharmaceuticalsNephroDI Therapeutics, and EpiVario.